rs794728746
Variant summary
Our verdict is Pathogenic. Variant got 19 ACMG points: 19P and 0B. PM1PM2PM5PP2PP3_StrongPP5_Very_Strong
The ENST00000366574.7(RYR2):c.6916G>A(p.Val2306Ile) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V2306F) has been classified as Likely pathogenic.
Frequency
Consequence
ENST00000366574.7 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 19 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RYR2 | NM_001035.3 | c.6916G>A | p.Val2306Ile | missense_variant | 45/105 | ENST00000366574.7 | NP_001026.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RYR2 | ENST00000366574.7 | c.6916G>A | p.Val2306Ile | missense_variant | 45/105 | 1 | NM_001035.3 | ENSP00000355533 | P1 | |
RYR2 | ENST00000660292.2 | c.6916G>A | p.Val2306Ile | missense_variant | 45/106 | ENSP00000499787 | ||||
RYR2 | ENST00000659194.3 | c.6916G>A | p.Val2306Ile | missense_variant | 45/105 | ENSP00000499653 | ||||
RYR2 | ENST00000609119.2 | c.6916G>A | p.Val2306Ile | missense_variant, NMD_transcript_variant | 45/104 | 5 | ENSP00000499659 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not provided Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Jun 03, 2021 | - - |
Catecholaminergic polymorphic ventricular tachycardia 1 Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Mar 13, 2016 | Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive, but these predictions have not been confirmed by published functional studies. Furthermore, this variant occurs within one of the three regions of the RYR2 gene (N-terminal domain) where other pathogenic variants have been reported to cluster (PMID: 19926015). In summary, this missense variant is absent from population databases, is predicted to be deleterious, and has been reported in affected patients as the result of a de novo events. For these reasons, this variant has been classified as Pathogenic. This variant has been reported in an individual affected with catecholaminergic polymorphic ventricular tachycardia (CPVT) and an individual that suffered a cardiac arrest (PMID: 14571276 and Invitae database). In both cases this variant presumably occurred as a de novo mutational event. ClinVar contains an entry for this variant (Variation ID: 201387). This variant is not present in population databases (ExAC no frequency). This sequence change replaces valine with isoleucine at codon 2306 of the RYR2 protein (p.Val2306Ile). The valine residue is highly conserved and there is a small physicochemical difference between valine and isoleucine. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at